What You Should Know:
The U.S. digital therapeutics market size is estimated to reach $21.46B by 2030, expanding at a CAGR of 33.8% from 2023 to 2030, according to a new reports by Coherent Market Insights, Inc. Digital therapeutics solutions help improve medication adherence with personalized incentives to encourage long-term behavior change in patients and people with chronic conditions. The report reveals government initiatives to digitalize healthcare is one of the key trends
Read More
Digital Therapeutics | Digital Health | Evidence-Based Therapeutics Interventions
Improving Physical Therapist and Patient Experiences with Technology Innovation
Today’s physical therapists are exhausted and drowning in debt from school loans. Looking at the physical therapy (PT) profession as a whole, there is an average turnover rate of 13.6%, a significant portion of the current healthcare industry’s staggering rate of 100.5% turnover, over the last 5 years, according to Daily Pay’s Healthcare Turnover Rates [2022 Edition]. What’s even more concerning is that 1 in 3 rehab professionals describe themselves as burnt-out.
What’s contributing to such
Read More
Expectations For The Connected Care Business In The Years Ahead
Though we seldom see their use in our modern world and, even then, only in fiction, there was a time when it was common for people to actually use things like crystal balls and divining rods to try to uncover unknown yet valuable information. As unbelievable as it may seem, soothsayers peered into crystal balls aiming to help seekers look into the future for guidance, while prospectors would rely earnestly on divining rods as they attempted to locate underground riches of water or oil.
While
Read More
ObvioHealth Launches Digital Therapeutics API for Clinical Trials
What You Should Know:
- ObvioHealth launches proprietary application programming interface (API) tailored specifically for digital therapeutics (DTx) clinical trials.
- ObvioHealth’s API ensures tight integration between the digital therapeutic and the ObvioGo platform, providing sponsors with accurate data to correlate efficacy with adherence to the DTx. In addition, ObvioGo’s integration reduces participant task duplication because—in most cases—outcomes can be passively captured
Read More
Curebase Launches Remote First DTx Research Platform
What You Should Know:
- Curebase, a company committed to democratizing access to clinical trials, announced the release of its integrated software and services package for digital therapeutics (DTx) trials that accelerates enrollment and allows sponsors to launch their studies faster.
- Available now, the new Curebase offering includes the first one-stop-shop decentralized clinical trial (DCT) platform bundled with site and trial execution services for the DTx market.
Making
Read More
The Patient Journey Tech Stack: 10 Pharma Predictions for 2023
The complexity of demands on Market Access teams has increased in recent years, between introducing innovative therapies targeting smaller populations and higher bars from Payers and PBMs.
Now, drug manufacturers are bucking up. According to the IQVIA Institute, the prescription abandonment rate has reached 27 percent, or $76 billion annually, in specialty drugs alone. This squandered revenue has led manufacturers to increase their focus on the complex, nuanced patient journey.
As a
Read More
Valencell Unveils Calibration-Free, Cuffless Blood Pressure Monitor
What You Should Know:
- Valencell, the company whose optical heart rate technology enabled the ability of wearables to accurately measure cardiovascular vitals during exercise, today announced plans to launch its own branded product line in the digital health sector as it concentrates efforts to bring solutions to market to manage chronic diseases.
- The company’s first product candidate being showcased at CES is focused on helping people monitor and manage hypertension by combining
Read More
BehaVR & Oxford VR Merge, Raises $13M for VR Delivery Platform
What You Should Know:
- Virtual reality mental and behavioral health companies BehaVR and OxfordVR today announced their merger, supported by an initial $13M in Series B funding led by Optum Ventures and Oxford Science Enterprises, with participation from Confluent Health, Accenture Ventures, Chrysalis Ventures and Thornton Capital.
- Uniting under the BehaVR brand, digital therapeutic companies BehaVR and OxfordVR will deliver comprehensive virtual reality-based treatments for mental and
Read More
HLTH22 Day 1 News Summary: Google, Maven, Highmark, LG, Others
Venture Capital, Private Equity Funding
Maven Clinic Secures $90M to Advance End-to-End Family Care Platform
Maven Clinic, the largest virtual clinic in women’s and family health raises $90 million Series E funding bringing its total funding to $300M. Maven plans to use the latest round of funding to advance its end-to-end family care platform to enable deeper personalization to meet the diverse needs of women and families everywhere.
Curavit Raises $5M for Digital Therapeutics
Read More
HLTH22: Curavit Raises $5M for Digital Therapeutics Clinical Research
What You Should Know:
- Curavit Clinical Research, a virtual contract research organization (VCRO) that specializes in decentralized clinical trials (DCTs) announced it raised $5M in Series A funding to accelerate its growing portfolio of research in the global digital therapeutics (DTx) market. The round was led by Osage Venture Partners with additional investment from Royal Street Ventures and Narrow Gauge Ventures.
- The new funding will be used to expand
Read More
